Development and validation of the novel subclassification of pN3 for patients with esophageal cancer

Overview of attention for article published in Frontiers in oncology, May 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 23,814 followers.

Development and validation of the novel subclassification of pN3 for patients with esophageal cancer https://t.co/8IH21SyrtL https://t.co/OAglS8TbXp

15 May 2023

Reply Repost Favourite

New research: Development and validation of the novel subclassification of pN3 for patients with esophageal cancer: Background Patients with stage pN3 esophageal cancer (EC) have a large number of metastatic lymph nodes (mLNs) and have poor… #oncology htt

14 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.